Clermont-Ferrand University Hospital
Clermont-Ferrand, Auvergne, 63000, France
NCT Number: NCT00336687
About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Clermont-Ferrand, Auvergne, 63000, France
About 40 % of the patients in reanimation are thrombopenics and the causes are not well known (reduction in platelet's production, increase in their destruction...). This protocol studies the epidemiology of thrombopenia for these patients and the impacts of cost and mortality in order to bring patients best medical cares.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: in reanimation
Time frame: in reanimation
University Hospital, Clermont-Ferrand
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06642740
Blood Platelet Disorders, Chronic Liver Disease
Beijing, Beijing Municipality, China
View Trial DetailsNCT04070599
Autoimmune Diseases, Autoimmune Thrombocytopenia
Bordeaux, France
View Trial DetailsNCT06455553
Blood Platelet Disorders, Cytopenia
Annecy, France
View Trial DetailsNCT01013181
Blood Platelet Disorders, Cytopenia
View Trial Details